Understanding Factors Influencing Decision Making during Assessment of Potential Organ Donors: A Qualitative Study of Clinicians Assessing the Medical Suitability of Potential Donors [0.03%]
潜在器官捐献者评估中影响判断因素的研究：关于评价潜在捐献者医学适宜性的医务人员的定性研究
Danielle Marie Muscat,Pinika Patel,Rachel Davies et al.
Danielle Marie Muscat et al.
Background. Potential organ donors are carefully assessed by expert clinicians (donation specialists) who evaluate a variety of factors, including balancing potential transplant benefits and biovigilance risks, under time constraints. We ai...
Treatment Preferences among Patients with Hormone-Sensitive Prostate Cancer in France, Spain, China, South Korea, and Japan: A Discrete-Choice Experiment [0.03%]
法国、西班牙、中国、韩国和日本的激素敏感性前列腺癌患者治疗偏好：一项离散选择实验
Juan Marcos Gonzalez,Arijit Ganguli,Alicia K Morgans et al.
Juan Marcos Gonzalez et al.
Background. Treatment preferences of patients with high-risk localized prostate cancer (HRLPC) and metastatic hormone-sensitive prostate cancer (mHSPC) are expected to be influenced by cultural and institutional differences across countries...
Exploring Key Elements of Surgical Shared Decision Making for Providers and Older Adults [0.03%]
探索外科手术共同决策的关键要素：医务人员和老年患者的视角
Gabriela Poles,Mariah Erlick,Alexis Zimmer et al.
Gabriela Poles et al.
Background. Shared decision making (SDM) is an essential component of patient-centered care and especially important in high-risk populations, such as older adults. Although surgery has unique risks and the potential to cause permanent disa...
Barriers and Facilitators for Shared Decision Making in Breast Reconstruction among Stakeholders in the Chinese Context: A Qualitative Study [0.03%]
中国背景下乳腺重建共决策的障碍与促进因素：一项定性研究
Xuejing Li,Meiqi Meng,Yiyi Yin et al.
Xuejing Li et al.
Objective. This qualitative study explores the barriers and facilitators to implementing shared decision making (SDM) for breast reconstruction (BR) from multistakeholder perspectives in the Chinese health care context. Methods. A qualitati...
Integrating Decision Science and Implementation Science to Inform Policy Decision Making [0.03%]
决策科学和转化科学的整合在政策制定中的应用
Natalie Riva Smith,Tran Thu Doan,Christina T Yuan et al.
Natalie Riva Smith et al.
Decision science and implementation science share the common goal of improving individual and population health through choosing and providing effective health innovations at scale. In this article, we summarize a symposium we hosted at the...
Designing DECIdE Together: An Interprofessional and Patient-Centered Approach to Develop a Patient Decision Aid for Drugs in Primary Care (DECIsion in hEalth) [0.03%]
DECIdE一起设计：一种跨专业和以患者为中心的方法，用于开发初级保健药物的患者决策支持工具（健康中的DECIsion）
Elodie Charuel,Thibault Menini,Sarah Chateauneuf et al.
Elodie Charuel et al.
Background. In primary care, general practitioners (GPs) and community pharmacists (CPs) play pivotal roles in guiding patients' drug choices. Nonprescription drugs (NPDs), which are dispensed with or without a prescription, represent signi...
Translation, Cultural Adaptation, and Validation of the International Patient Decision Aid Standards Minimal Criteria Instrument for the Portuguese Population [0.03%]
国际患者决策辅助标准最低限度标准量表的翻译、文化改编及验证（葡萄牙语版）
Micaela Gregório,Andreia Teixeira,Mariana Teixeira et al.
Micaela Gregório et al.
Introduction. Patient decision aids support health care decision making by dynamically integrating evidence-based information with patients' values, goals, and preferences. However, most of these aids are available only in English, limiting...
Patient Preferences in Neoadjuvant Therapy for HER2+ Early-Stage Breast Cancer [0.03%]
HER2阳性早期乳腺癌新辅助治疗的患者偏好分析
Laurie Batchelder,Laure Guéroult-Accolas,Eirini Anastasaki et al.
Laurie Batchelder et al.
Purpose. Health technology assessment (HTA) focuses on overall survival (OS) as the key clinical endpoint when making oncology treatment decisions. However, capturing robust OS estimates in early-stage breast cancer (eBC) is challenging, an...
Development and Qualitative Evaluation of a Decision Support Tool for Withdrawal of Biologic Therapy in Nonsystemic Juvenile Idiopathic Arthritis [0.03%]
生物制剂治疗非系统性幼年特发性关节炎减停决策支持工具的开发和定性评估
Janine A van Til,Michelle M A Kip,Robert Marinescu-Muster et al.
Janine A van Til et al.
Introduction. Limited evidence guides pediatric rheumatologists on when to withdraw biologic therapy in children with juvenile idiopathic arthritis, resulting in wide variation in clinical practice. This study aimed to develop and evaluate ...
Development and Acceptability Testing of a Patient Decision Aid on Levodopa Intestinal Gel for Parkinson Disease [0.03%]
帕金森病患者关于左旋多巴肠凝胶的决策辅助工具的开发和接受性测试
Andreanne Tanguay,Caroline Cayer,Isabelle Beaulieu-Boire
Andreanne Tanguay
Background: Parkinson's disease (PD) is a neurodegenerative disease characterized by motor and nonmotor symptoms that worsen over time. In some cases, an advanced treatment may be needed. The use of levodopa-carbidopa int...